NASDAQ:SILKSilk Road Medical Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Silk Road Medical Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $34.82 +4.75 (+15.80 %) (As of 04/7/2020 08:48 AM ET) Add Compare Share Today's Range$31.18Now: $34.82▼$35.6850-Day Range$23.16MA: $36.10▼$47.2052-Week Range$20.84Now: $34.82▼$51.50Volume355,574 shsAverage Volume376,495 shsMarket Capitalization$1.09 billionP/E RatioN/ADividend YieldN/ABetaN/A ProfileAnalyst RatingsAdvanced ChartEarningsInsider TradesInstitutional OwnershipHeadlinesSocial Media Silk Road Medical, Inc. operates as a medical device company in the United States. It offers ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and initiate temporary blood flow reversal; ENROUTE Transcarotid Stent System, a self-expanding, self-tapering stent with clinical data regarding lasting safety outcomes; ENHANCE Transcarotid Peripheral Access Kit for use in gaining initial access to the common carotid artery; and ENROUTE 0.014 Guidewire for navigating and crossing the target lesion for delivery of interventional devices. The company was founded in 2007 and is headquartered in Sunnyvale, California.Read More Beat the Market (BTM) Rank™ 3.4 Analyst's Opinion Consensus RatingSilk Road Medical has received a consensus rating of Buy. The company's average rating score is 2.80, and is based on 4 buy ratings, 1 hold rating, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $46.20, Silk Road Medical has a potential upside of 32.7% from its current price of $34.82.Amount of Analyst CoverageSilk Road Medical has only been the subject of 1 research reports in the past 90 days. Previous Next 2.4 Community Rank Outperform VotesSilk Road Medical has received 56 “outperform” votes. (Add your “outperform” vote.)Underperform VotesSilk Road Medical has received 62 “underperform” votes. (Add your “underperform” vote.)Community SentimentSilk Road Medical has received 52.54% “underperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Silk Road Medical and other stocks. Vote “Outperform” if you believe SILK will outperform the S&P 500 over the long term. Vote “Underperform” if you believe SILK will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldSilk Road Medical does not currently pay a dividend.Dividend GrowthSilk Road Medical does not have a long track record of dividend growth. Previous Next 1.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Silk Road Medical insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $3,632,801.00 in company stock.Percentage Held by Institutions93.19% of the stock of Silk Road Medical is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 0.0 Earnings and Valuation Earnings GrowthEarnings for Silk Road Medical are expected to decrease by -63.11% in the coming year, from ($1.03) to ($0.38) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Silk Road Medical is -1.65, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Silk Road Medical is -1.65, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioSilk Road Medical has a P/B Ratio of 14.94. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next Analyst Opinion: 3.4Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™1.36 out of 5 stars Industry, Sector and Symbol Stock Exchange NASDAQ Industry Surgical & medical instruments Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:SILK Previous Symbol CUSIPN/A CIKN/A Webhttp://www.silkroadmed.com/ Phone408-720-9002Debt Debt-to-Equity Ratio0.62 Current Ratio6.64 Quick Ratio6.03Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$63.35 million Price / Sales17.23 Cash FlowN/A Price / Cash FlowN/A Book Value$2.33 per share Price / Book14.94Profitability EPS (Most Recent Fiscal Year)($1.36) Net Income$-52,420,000.00 Net Margins-82.73% Return on Equity-165.90% Return on Assets-27.44%Miscellaneous Employees176 Outstanding Shares31,350,000Market Cap$1.09 billion Next Earnings Date5/13/2020 (Estimated) OptionableNot Optionable Receive SILK News and Ratings via Email Sign-up to receive the latest news and ratings for SILK and its competitors with MarketBeat's FREE daily newsletter. NASDAQ:SILK Rates by TradingView Silk Road Medical (NASDAQ:SILK) Frequently Asked Questions How has Silk Road Medical's stock been impacted by COVID-19 (Coronavirus)? Silk Road Medical's stock was trading at $37.14 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, SILK shares have decreased by 6.2% and is now trading at $34.82. View which stocks have been mosted impacted by Coronavirus. Do Wall Street analysts recommend investors buy shares of Silk Road Medical? 5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Silk Road Medical in the last year. There are currently 1 hold rating and 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Silk Road Medical. When is Silk Road Medical's next earnings date? Silk Road Medical is scheduled to release its next quarterly earnings announcement on Wednesday, May 13th 2020. View our earnings forecast for Silk Road Medical. How were Silk Road Medical's earnings last quarter? Silk Road Medical Inc (NASDAQ:SILK) posted its earnings results on Wednesday, February, 26th. The company reported ($0.27) EPS for the quarter, hitting the Thomson Reuters' consensus estimate of ($0.27). The company earned $18.63 million during the quarter, compared to the consensus estimate of $17.90 million. Silk Road Medical had a negative return on equity of 165.90% and a negative net margin of 82.73%. View Silk Road Medical's earnings history. What guidance has Silk Road Medical issued on next quarter's earnings? Silk Road Medical updated its FY 2020 After-Hours earnings guidance on Wednesday, February, 26th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $92-95 million, compared to the consensus revenue estimate of $94.02 million. What price target have analysts set for SILK? 5 Wall Street analysts have issued 1-year price objectives for Silk Road Medical's stock. Their forecasts range from $40.01 to $52.00. On average, they anticipate Silk Road Medical's stock price to reach $46.20 in the next year. This suggests a possible upside of 32.7% from the stock's current price. View analysts' price targets for Silk Road Medical. Has Silk Road Medical been receiving favorable news coverage? Media stories about SILK stock have trended very negative on Tuesday, InfoTrie reports. The research firm identifies positive and negative news coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Silk Road Medical earned a daily sentiment score of -3.3 on InfoTrie's scale. They also gave media stories about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the stock's share price in the next several days. View the latest news aboutSilk Road Medical. Who are some of Silk Road Medical's key competitors? Some companies that are related to Silk Road Medical include Tandem Diabetes Care (TNDM), Integra Lifesciences (IART), Nevro (NVRO), NuVasive (NUVA), Irhythm Technologies (IRTC), Merit Medical Systems (MMSI), Cantel Medical (CMD), Glaukos (GKOS), AtriCure (ATRC), Atrion (ATRI), Cardiovascular Systems (CSII), Luminex (LMNX), Inspire Medical Systems (INSP), Inovio Pharmaceuticals (INO) and Shockwave Medical (SWAV). What other stocks do shareholders of Silk Road Medical own? Based on aggregate information from My MarketBeat watchlists, some companies that other Silk Road Medical investors own include Alibaba Group (BABA), Splunk (SPLK), salesforce.com (CRM), Home Depot (HD), Honeywell International (HON), Thermo Fisher Scientific (TMO), Cisco Systems (CSCO), DexCom (DXCM), CVS Health (CVS) and AT&T (T). Who are Silk Road Medical's key executives? Silk Road Medical's management team includes the following people: Ms. Erica J. Rogers, Chief Exec. Officer, Pres & Director (Age 55)Mr. Lucas W. Buchanan, Chief Financial Officer (Age 41)Mr. Robert A. Nicholas, VP of Operations & Engineering (Age 56)Mr. Andrew S. Davis, Exec. VP of Global Sales & Marketing (Age 50)Ms. Alison Highlander, VP of HR When did Silk Road Medical IPO? (SILK) raised $75 million in an IPO on Thursday, April 4th 2019. The company issued 4,700,000 shares at $15.00-$17.00 per share. J.P. Morgan and BofA Merrill Lynch served as the underwriters for the IPO and BMO Capital Markets and Stifel were co-managers. What is Silk Road Medical's stock symbol? Silk Road Medical trades on the NASDAQ under the ticker symbol "SILK." How do I buy shares of Silk Road Medical? Shares of SILK can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is Silk Road Medical's stock price today? One share of SILK stock can currently be purchased for approximately $34.82. How big of a company is Silk Road Medical? Silk Road Medical has a market capitalization of $1.09 billion and generates $63.35 million in revenue each year. The company earns $-52,420,000.00 in net income (profit) each year or ($1.36) on an earnings per share basis. Silk Road Medical employs 176 workers across the globe. View additional information about Silk Road Medical. What is Silk Road Medical's official website? The official website for Silk Road Medical is http://www.silkroadmed.com/. How can I contact Silk Road Medical? Silk Road Medical's mailing address is 1213 INNSBRUCK DR., SUNNYVALE CA, 94089. The company can be reached via phone at 408-720-9002 or via email at [email protected] This page was last updated on 4/7/2020 by MarketBeat.com StaffFeatured Article: CBOE Russell 2000® Volatility Index
